Traders Buy Morgan Stanley (MS) on Weakness

Traders bought shares of Morgan Stanley (NYSE:MS) on weakness during trading hours on Monday. $99.33 million flowed into the stock on the tick-up and $39.04 million flowed out of the stock on the tick-down, for a money net flow of $60.29 million into the stock. Of all stocks tracked, Morgan Stanley had the 10th highest net in-flow for the day. Morgan Stanley traded down ($0.12) for the day and closed at $52.77

Several analysts have issued reports on the company. Zacks Investment Research raised Morgan Stanley from a “hold” rating to a “buy” rating and set a $59.00 target price on the stock in a research report on Monday. Buckingham Research increased their target price on Morgan Stanley from $54.00 to $57.00 and gave the company a “buy” rating in a research report on Wednesday, October 18th. Keefe, Bruyette & Woods raised Morgan Stanley from a “market perform” rating to an “outperform” rating and set a $59.00 target price on the stock in a research report on Tuesday. Oppenheimer reaffirmed a “hold” rating on shares of Morgan Stanley in a research report on Tuesday, October 17th. Finally, BMO Capital Markets reaffirmed a “top pick” rating and set a $69.00 target price on shares of Morgan Stanley in a research report on Wednesday, October 18th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $50.89.

The company has a market capitalization of $95,402.84, a P/E ratio of 14.62, a PEG ratio of 1.24 and a beta of 1.64. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 2.68.

Morgan Stanley (NYSE:MS) last issued its earnings results on Tuesday, October 17th. The financial services provider reported $0.93 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.12. The company had revenue of $9.20 billion during the quarter, compared to analyst estimates of $9.05 billion. Morgan Stanley had a return on equity of 10.07% and a net margin of 16.76%. The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the business posted $0.80 EPS. research analysts predict that Morgan Stanley will post 3.57 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Tuesday, October 31st were paid a $0.25 dividend. The ex-dividend date was Monday, October 30th. This represents a $1.00 dividend on an annualized basis and a yield of 1.86%. Morgan Stanley’s dividend payout ratio (DPR) is 27.70%.

In other Morgan Stanley news, insider Keishi Hotsuki sold 25,000 shares of Morgan Stanley stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $50.00, for a total transaction of $1,250,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Alistair Darling sold 3,850 shares of Morgan Stanley stock in a transaction dated Friday, November 24th. The shares were sold at an average price of $49.29, for a total value of $189,766.50. Following the transaction, the director now owns 14,218 shares of the company’s stock, valued at approximately $700,805.22. The disclosure for this sale can be found here. Insiders sold a total of 85,247 shares of company stock valued at $4,284,364 in the last 90 days. 0.24% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Catamount Wealth Management increased its stake in shares of Morgan Stanley by 0.3% in the 2nd quarter. Catamount Wealth Management now owns 32,477 shares of the financial services provider’s stock valued at $1,447,000 after purchasing an additional 100 shares in the last quarter. HM Payson & Co. increased its stake in shares of Morgan Stanley by 1.4% in the 2nd quarter. HM Payson & Co. now owns 7,457 shares of the financial services provider’s stock valued at $332,000 after purchasing an additional 106 shares in the last quarter. Davidson & Garrard Inc. increased its stake in shares of Morgan Stanley by 2.2% in the 2nd quarter. Davidson & Garrard Inc. now owns 5,525 shares of the financial services provider’s stock valued at $246,000 after purchasing an additional 120 shares in the last quarter. Omnia Family Wealth LLC increased its stake in shares of Morgan Stanley by 5.8% in the 2nd quarter. Omnia Family Wealth LLC now owns 2,429 shares of the financial services provider’s stock valued at $108,000 after purchasing an additional 134 shares in the last quarter. Finally, Savant Capital LLC increased its stake in shares of Morgan Stanley by 1.9% in the 2nd quarter. Savant Capital LLC now owns 9,863 shares of the financial services provider’s stock valued at $439,000 after purchasing an additional 186 shares in the last quarter. Institutional investors and hedge funds own 85.60% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://ledgergazette.com/2017/12/13/traders-buy-morgan-stanley-ms-on-weakness.html.

Morgan Stanley Company Profile

Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply